A Randomized Double-Blind Placebo-Controlled Multi-Centre Pilot Study to Assess Symptom Response in Subjects With Pain or Discomfort in the Chest Receiving Oral Treatment With Esomeprazole 40 Mg Bid for 4 Weeks

Trial Profile

A Randomized Double-Blind Placebo-Controlled Multi-Centre Pilot Study to Assess Symptom Response in Subjects With Pain or Discomfort in the Chest Receiving Oral Treatment With Esomeprazole 40 Mg Bid for 4 Weeks

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Jan 2011

At a glance

  • Drugs Esomeprazole (Primary)
  • Indications Heartburn
  • Focus Pharmacodynamics; Therapeutic Use
  • Sponsors AstraZeneca
  • Most Recent Events

    • 21 Jan 2011 Trial phase changed from II to III as reported by ClinicalTrials.gov.
    • 13 Jun 2007 Status change. Results data published.
    • 13 Jun 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top